[Genetic epidemiology of multiple sclerosis]. 2002

D F Uría
Servicio de Neurología. Hospital San Agustín. Avilés, Asturias, España. dfernandezu@mednet.com

BACKGROUND Although multiple sclerosis (EM) has the characteristics of a disorder which is complex to study epidemiologically, many papers have been published on its genetic epidemiology, and these have given a great deal of information regarding the aetiological factors of the disorder. METHODS These epidemiological investigations have also studied the incidence and prevalence of EM in each zone, the different geographical distribution, its variation with immigration, relation to race and sex, the existence of possible epidemics or groups and its family aggregation. They have supported the environmental aetiological factor of EM, the geographical gradient of the frequency, possible epidemics or groups, changes with migrations and concordance in identical twins of less than 100%. However, arguments in favour of a genetic aetiological factor have been supported by racial differences in the frequency of this disorder, the existence of resistant ethnic groups in spite of the migrations and the increased concordance in monozygotic twins. CONCLUSIONS The results of studies on the genetic epidemiology of EM support the multifactorial nature of its aetiology, with a polygenic type of genetic susceptibility, although this alone does not justify the development of EM. Some environmental factor, as yet unknown, is necessary for the disease to develop in a genetically susceptible person. Molecular genetic studies are adding further knowledge about this genetic susceptibility, although the genes involved have not yet been conclusively identified because of the complexity of EM.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D F Uría
June 1997, Journal of neurology, neurosurgery, and psychiatry,
D F Uría
January 1997, Epidemiologic reviews,
D F Uría
June 1996, Current opinion in neurology,
D F Uría
October 2003, Journal of neuroimmunology,
D F Uría
October 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
D F Uría
December 1994, Annals of neurology,
D F Uría
October 2015, Multiple sclerosis (Houndmills, Basingstoke, England),
D F Uría
August 2003, Nihon rinsho. Japanese journal of clinical medicine,
D F Uría
September 2015, Annals of Indian Academy of Neurology,
D F Uría
January 1980, British medical journal,
Copied contents to your clipboard!